Alzamend Neuro to Present at the 2025 Military Health System Research Symposium

"Our upcoming poster presentation at MHSRS 2025 represents an exceptional opportunity to spotlight our cutting-edge innovation and its transformative potential for active-duty service members and military veterans," said Stephan Jackman, Chief Executive Officer of Alzamend. "We are excited to engage with Department of Defense (DoD) funding directors to pursue non-dilutive funding through grants, which would further validate our technology and accelerate our advancement while strategically preserving shareho ...